Backed by one-year EPS and revenue growth estimates of 21.72% and 16.23%, respectively, Eli Lilly and Company (NYSE:LLY) ...

Eli Lilly and Company (NYSE:LLY) is among the 15 Best Big Name Stocks to Buy. On April 21, Barclays analyst Emily Field ...

Eli Lilly's $7 billion deal for Kelonia Therapeutics on Monday was just the latest example | Despite the recent “feeding ...

Eli Lilly is set to report first-quarter results before the market opens Thursday. Here is what you need to know. PROFIT: The pharmaceutical company is projected to post a profit of $6.61 billion, ...

Eli Lilly has more to offer than some investors realize.

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

Eli Lilly said on Monday ​it would buy ​privately ​held blood cancer treatment developer Ajax Therapeutics for up to $2.3 ...

With six acquisitions already this year, Eli Lilly’s business development shows no signs of stopping as executives make good ...

What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for it? Bryan Roberts ...

If you're looking to add to your long-term stock portfolio, it can make good sense to consider a healthcare stock. After all, ...

Minnesota-based UnitedHealth ( UNH) reported $111.7B in revenue for the quarter with ~2% YoY growth, exceeding the consensus by $2.1B, thanks mainly to its insurance segment. Meanwhile, its non-GAAP ...

With the ink barely dry on an agreement to buy Kelonia, Eli Lilly has signed a deal to take ownership of Ajax Therapeutics ...